A review of the toxic effects and mechanisms of action of fumonisin B 1

Human and Experimental Toxicology

Volumn 27, Issue 11, 2008, Pages 799-809

  Stockmann Juvala, H ^a   Savolainen, K ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Apoptosis; Fumonisin B1; Mechanisms; Oxidative stress; Toxicity

Indexed keywords

FUMONISIN; FUMONISIN B1; FUMONISIN B2; FUMONISIN B3; SPHINGOLIPID; SPHINGOSINE ACYLTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INCIDENCE; CARCINOGENICITY; CORN; CROP; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TOLERABILITY; ESOPHAGUS CANCER; FUSARIUM; FUSARIUM VERTICILLIOIDES; HUMAN; IMMUNOSTIMULATION; LEUKOENCEPHALOMALACIA; LIVER TOXICITY; LUNG EDEMA; MYCOTOXICOSIS; NEPHROTOXICITY; NEURAL TUBE DEFECT; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; CARCINOGENS, ENVIRONMENTAL; FEMALE; FUMONISINS; HUMANS; PREGNANCY; TERATOGENS;

ANIMALIA; FUNGI; FUSARIUM; GIBBERELLA MONILIFORMIS; ZEA MAYS;

EID: 60149106152     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327108099525     Document Type: Review

References (100)

1. Marasas WFO.. Discovery and occurrence of fumonisins: a historical perspective. Environ Health Perspect 2001 ; 109: 239-243.
2. Gelderblom WCA. Jaskiewicz K. Marasas WFO. Thiel PG. Horak RM. Vleggar R.. Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988 ; 54: 1806-1811.
3. Bezuidenhout SC;.Gelderblom WCA;.Gorst-Allman CP;.Horak RM;.Marasas WFO;.Spiteller G;.. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme. J Chem Soc Chem Commun 1988; 743-745.
4. Moss MO.. Recent studies of mycotoxins. J Appl Microbiol 1998 ; (Suppl. 84): 62-76.
5. Dutton MF.. Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol Ther 1996 ; 70: 137-161.
6. WHO. Fumonisin B1 (Environmental health criteria 219). International programme on chemical safety. Geneva: World Health Organization ; 2000.
7. Gelderblom WCA. Cawood ME. Snyman SD. Vleggaar R. Marasas WFO.. Structre-activity relationships of fumonisins in short-term carcinogenesis and cytotoxicity assays. Food Chem Toxicol 1993 ; 31: 407-414.
8. Norred WP. Plattner R-D. Dombrink-Kurtzman MA. Meredith FI. Riley RT.. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Toxicol Appl Pharmacol 1997 ; 147: 63-70.
9. Howard PC. Couch LH. Patton RE. Eppley RM. Doerge DL. Churchwell MI.. Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F1 mice. Toxicol Appl Pharmacol 2002 ; 185: 153-165.
10. WHO. IARC monographs on the evaluation of carcinogenic risk to humans. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, vol. 56. Lyon: IARC ; 1993. p. 445-466.
11. WHO. IARC monographs on the evaluation of carcinogenic risk to humans. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene, vol. 82. Lyon: IARC Press ; 2002. p. 301-366.
12. WHO. Safety evaluation of certain mycotoxins in food (WHO food additives series 47). International programme on chemical safety. Geneva: World Health Organization ; 2001. p. 103-279.
13. Bhat RV. Shetty PH. Amruth RP. Sudershan RV.. A foodborne disease outbreak due to the consumption of moldy sorghum and maize containing fumonisin mycotoxins. Clin Toxicol 1997 ; 35: 249-255.
14. Abbas HK. Cartwright RD. Shier WT. Abouzied MM. Bird CB. Rice LG.. Natural occurrence of fumonisins in rice with Fusarium sheath rot disease. Plant Dis 1998 ; 82: 22-25.
15. da Silva JB. Pozzi CR. Mallozzi MAB. Ortega EM. Corrêa B.. Mycoflora and occurrence of aflatoxin B1 and fumonisin B1 during storage of Brazilian sorghum. J Agric Food Chem 2000 ; 48: 4352-4356.
16. Beg MU. Al-Mutairi M. Beg KR. Al-Mazeedi HM. Ali LN. Saeed T.. Mycotoxins in poultry feed in Kuwait. Arch Environ Contam Toxicol 2006 ; 50: 594-602.
17. Cirillo T. Ritieni A. Galvano F. Amodio Cocchieri R.. Natural co-occurrence of deoxynivalenol and fumonisins B1 and B2 in Italian marketed foodstuffs. Food Addit Contam 2003 ; 20: 566-571.
18. Cirillo T. Ritieni A. Visone M. Amodio Cocchieri R.. Evaluation of conventional and organic Italian foodstuffs for deoxynivalenol and fumonisins B1 and B2. J Agric Food Chem 2003 ; 51: 8128-8131.
19. Shephard GS. van der Westhuizen L. Gatyeni PM. Katerere DR. Marasas WFO.. Do fumonisin mycotoxins occur in wheat. J Agric Food Chem 2005 ; 53: 9293-9296.
20. Hunter CA. Grant C. Flannigan B. Bravery AF.. Mould in buildings: the air spora of domestic dwellings. Int Biodeterior 1988 ; 24: 81-101.
21. Grant C. Hunter CA. Flannigan B. Bravery AF.. The moisture requirements of moulds isolated from domestic dwellings. Int Biodeterior 1989 ; 25: 259-284.
22. Tuomi T. Reijula K. Johnsson T. Hemminki K. Hintikka E-L. Lindroos O.. Mycotoxins in crude building materials from water-damaged buildings. Appl Environ Microbiol 2000 ; 66: 1899-1904.
23. Merrill AH. Schmelz E-M. Dillehay DL. Spiegel S. Shayman JA. Schroeder JJ.. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997 ; 142: 208-225.
24. Merrill AH. Sullards MC. Wang E. Voss KA. Riley RT.. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect 2001 ; 109: 283-289.
25. Wang E. Norred WP. Bacon CW. Riley RT. Merrill AH.. Inhibition of sphingolipid biosynthesis by fumonisins. J Biol Chem 1991 ; 22: 14486-14490.
26. Wang E. Ross PF. Wilson TM. Riley RT. Merrill AH.. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J Nutr 1992 ; 122: 1706-1716.
27. Wang E. Riley RT. Meredith FI. Merrill AH.. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine. J Nutr 1999 ; 129: 214-220.
28. Yoo H-S. Norred WP. Wang E. Merrill AH. Riley RT.. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol 1992 ; 114: 9-15.
29. Enongene EN. Sharma RP. Bhandari N. Voss KA. Riley RT.. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1. Food Chem Toxicol 2000 ; 38: 793-799.
30. Delongchamp RR. Young JF.. Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Food Addit Contam 2001 ; 18: 255-261.
31. Sydenham EW. Theil PG. Marasas WFO. Shephard GS. van Schalkwyk DJ. Koch KR.. Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, Southern Africa. J Agric Food Chem 1990 ; 38: 1900-1903.
32. Chu FS. Li GY.. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol 1994 ; 60: 847-852.
33. Abnet CC. Borkowf CB. Qiao Y-L. Albert PS. Wang E. Merrill AH.. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China. Cancer Causes Control 2001 ; 12: 821-828.
34. Hendricks K.. Fumonisins and neural tube defects in South Texas. Epidemiology 1999 ; 10: 198-200.
35. Missmer SA. Suarez L. Felkner M. Wang E. Merrill AH. Rothman KJ.. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect 2006 ; 114: 237-241.
36. Cornell J. Nelson MM. Beighton P.. Neural tube defects in Cape Town area, 1975-1980. S Afr Med J 1983 ; 64: 83-84.
37. Ncayiyana DJ.. Neural tube defects among rural blacks in a Transkei district. S Afr Med J 1986 ; 69: 618-620.
38. Moore CA. Li S. Li Z. Hong S. Gu H. Berry RJ.. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 1997 ; 73: 113-118.
39. Werler MM. Louik C. Mitchell AA.. Achieving a public health recommendation for preventing neural tube defects with folic acid. Am J Public Health 1999 ; 89: 1637-1640.
40. Blom HJ. Shaw GM. den Heijer M. Finnell RH.. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006 ; 7: 724-731.
41. Marasas WFO. Riley RT. Hendricks KA. Stevens VL. Sadler TW. Gelineau-van Waes J.. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 2004 ; 134: 711-716.
42. Martinez-Larranga MR. Anadon A. Diaz MJ. Fernandez-Cruz ML. Frejo MT. Martinez M.. Toxicokinetics and oral bioavailability of fumonisin B1. Vet Hum Toxicol 1999 ; 41: 357-362.
43. Shephard GS. Thiel PG. Sydenham EW.. Initial studies on the toxicokinetics of fumonisin B1. Food Chem Toxicol 1992 ; 30: 277-279.
44. Shephard GS. Thiel PG. Sydenham EW. Alberts JF.. Biliary excretion of the mycotoxin fumonisin B1 in rats. Food Chem Toxicol 1994 ; 32: 489-491.
45. Prelusky DB. Miller JD. Trenholm HL.. Disposition of 14C-derived residues in tissues of pigs fed radiolabelled fumonisin B1. Food Addit Contam 1996 ; 13: 155-162.
46. Voss KA. Riley RT. Norred WP. Bacon CW. Meredith FI. Howard PC.. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect 2001 ; 109: 259-266.
47. Shephard GS. Thiel PG. Sydenham EW. Vleggaar R. Alberts JF.. Determination of the mycotoxin fumonisin B1 and identification of its partially hydrolysed metabolites in the faeces of non-human primates. Food Chem Toxicol 1994 ; 32: 23-29.
48. Marasas WFO. Kellerman TS. Gelderblom WCA. Coetzer JAW. Thiel PG. van der Lugt JJ.. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 1988 ; 55: 197-203.
49. Kellerman TS. Marasas WFO. Thiel PG. Gelderblom WCA. Cawood M. Coetzer JAW.. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J Vet Res 1990 ; 57: 269-275.
50. Wilson TM. Ross PF. Owens DL. Rice LG. Green SA. Jenkins SJ.. Experimental reproduction of ELEM. Mycopathologia 1992 ; 117: 115-120.
51. Ross PF. Ledet AE. Owens DL. Rice LG. Nelson HA. Osweiler GD.. Experimental equine leukoencephalomalacia, toxic hepatosis, and encephalopathy caused by corn naturally contaminated with fumonisins. J Vet Diagn Invest 1993 ; 5: 69-74.
52. Smith GW. Constable PD. Foreman JH. Eppley RM. Waggoner AL. Tumbleson ME.. Cardiovascular changes associated with intravenous administration of fumonisin B1 in horses. Am J Vet Res 2002 ; 63: 538-545.
53. Haschek WM. Gumprecht LA. Smith G. Tumbleson ME. Constable PD.. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ Health Perspect 2001 ; 109: 251-257.
54. Haschek WM. Motelin G. Ness DK. Harlin KS. Hall WF. Vesonder RF.. Characterization of fumonisin toxicity in orally and intravenously dosed swine. Mycopathologia 1992 ; 117: 83-96.
55. Zomborszky MK. Vetési F. Repa I. Kovács F. Bata A. Horn P.. Experiment to determine limits of tolerance for fumonisin B1 in weaned piglets. J Vet Med B 2000 ; 47: 277-286.
56. Constable PD. Smith GW. Rottinghaus GE. Haschek WM.. Ingestion of fumonisin B1-containing culture material decreases cardiac contractility and mechanical efficiency in swine. Toxicol Appl Pharmacol 2000 ; 162: 151-160.
57. Smith GW. Constable PD. Eppley RM. Tumbleson ME. Gumprecht LA. Haschek-Hock WM.. Purified fumonisin B1 decreases cardiovascular function but does not alter pulmonary capillary permeability in swine. Toxicol Sci 2000 ; 56: 240-249.
58. Bondy GS. Suzuki CAM. Mueller RW. Fernie SM. Armstrong CL. Hierlihy SL.. Gavage administration of the fungal toxin fumonisin B1 to female Sprague-Dawley rats. J Toxicol Environ Health A 1998 ; 53: 135-151.
59. Bondy GS. Suzuki CAM. Fernie SM. Armstrong CL. Hierlihy SL. Savard ME.. Toxicity of fumonisin B1 to B6C3F1 mice: a 14-day gavage study. Food Chem Toxicol 1997 ; 35: 981-989.
60. Bondy G. Suzuki C. Barker M. Armstrong C. Fernie S. Hierlihy L.. Toxicity of fumonisin B1 administered intraperitoneally to male Sprague-Dawley rats. Food Chem Toxicol 1995 ; 33: 653-665.
61. Tolleson WH. Dooley KL. Sheldon WG. Thurman JD. Bucci TJ. Howard PC.. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. In: Jackson, LS, DeVries, JW, Bullerman, LB, (eds), Advances in experimental and medical biology. New York: Fumonisins in food, Plenum Press; 1996. p. 237-250.
62. Lemmer ER. de la Motte Hall P. Omori N. Omori M. Shephard EG. Gelderblom WCA.. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme. Carcinogenesis 1999 ; 20: 817-824.
63. Howard PC. Eppley RM. Stack ME. Warbritton A. Voss KA. Lorentzen RJ.. Fumonisin B1 carcinogenicity in a two-year feeding study using F344 rats and B6C3 F1 mice. Environ Health Perspect 2001 ; 109: 277-282.
64. Mobio TA. Anane R. Baudrimont I. Carratú M-R. Shier TW. Dano SD.. Epigenetic properties of fumonisin B1: cell cycle arrest and DNA base modification in C6 glioma cells. Toxicol Appl Pharmacol 2000 ; 164: 91-96.
65. Stevens VL. Tang J.. Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem 1997 ; 272: 18020-18025.
66. Sadler TW. Merrill AH. Stevens VL. Sullards MC. Wang E. Wang P.. Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 2002 ; 66: 169-176.
67. Gelderblom WCA. Abel S. Smuts CM. Marnewick J. Marasas WFO. Lemmer ER.. Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ Health Perspect 2001 ; 109: 291-300.
68. Howard PC. Warbritton A. Voss KA. Lorentzen RJ. Thurman JD. Kovach RM.. Compensatory regeneration as a mechanism for renal tubule carcinogenesis of fumonisin B1 in the F344/N/Nctr BR rat. Environ Health Perspect 2001 ; 109: 309-314.
69. http://www.cfsan.fda.gov/∼dms/
70. Stockmann-Juvala H. Mikkola J. Naarala J. Loikkanen J. Elovaara E. Savolainen K.. Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures. Free Radic Res 2004 ; 38: 933-942.
71. Stockmann-Juvala H. Mikkola J. Naarala J. Loikkanen J. Elovaara E. Savolainen K.. Fumonisin B1-induced toxicity and oxidative stress in U-118MG glioblastoma cells. Toxicology 2004 ; 202: 173-183.
72. Galvano F. Russo A. Cardile V. Galvano G. Vanella A. Renis M.. DNA damage in human fibroblasts exposed to fumonisin B1. Food Chem Toxicol 2002 ; 40: 25-31.
73. Galvano F. Campisi A. Russo A. Galvano G. Palumbo M. Renis M.. DNA damage in astrocytes exposed to fumonisin B1. Neurochem Res 2002 ; 27: 345-351.
74. Theumer MG. López AG. Masih DT. Chulze SN. Rubinstein HR.. Immunobiological effects of fumonisin B1 in experimental subchronic mycotoxicoses in rats. Clin Diagn Lab Immunol 2002 ; 9: 149-155.
75. Abado-Becognee K. Mobio TA. Ennamany R. Fleurat-Lessard F. Shier WT. Badria F.. Cytotoxicity of fumonisin B1: implication of lipid peroxidation and inhibition of protein and DNA syntheses. Arch Toxicol 1998 ; 72: 233-236.
76. Abel S. Gelderblom WCA.. Oxidative damage and fumonisin B1-induced toxicity in primary rat hepatocytes and rat liver in vivo. Toxicology 1998 ; 131: 121-131.
77. Mobio TA. Tavan E. Baudrimont I. Anane R. Carratú M-R. Sanni A.. Comparative study of the toxic effects of fumonisin B1 in rat C6 glioma cells and p53-null mouse embryo fibroblasts. Toxicology 2003 ; 183: 65-75.
78. Kouadio JH. Mobio TA. Baudrimont I. Moukha S. Dano SD. Creppy EE.. Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology 2005 ; 213: 56-65.
79. Yin J-J. Smith MH. Eppley RM. Page SW. Sphon JA.. Effects of fumonisin B1 on lipid peroxidation in membranes. Biochim Biophys Acta 1998 ; 1371: 134-142.
80. Osuchowski MF. Sharma RP.. Fumonisin B1 induces necrotic cell death in BV-2 cells and murine cultured astrocytes and is antiproliferative in BV-2 cells while N2A cells and primary cortical neurons are resistant. Neurotoxicology 2005 ; 26: 981-992.
81. Tolleson WH. Melchior WB. Morris SM. McGarrity LJ. Domon OE. Muskhelishvili L.. Apoptotic and anti-proliferative effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis 1996 ; 17: 239-249.
82. Monnet-Tschudi F. Zurich M-G. Sorg O. Matthieu J-M. Honegger P. Schilter B.. The naturally occurring food mycotoxin fumonisin B1 impairs myelin formation in aggregating brain cell culture. Neurotoxicology 1999 ; 20: 41-48.
83. Schmelz EM. Dombrink-Kurtzman MA. Roberts PC. Kozutsumi Y. Kawasaki T. Merrill AH.. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol Appl Pharmacol 1998 ; 148: 252-260.
84. Seefelder W. Humpf H-U. Schwerdt R. Freudinger R. Gekle M.. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol Appl Pharmacol 2003 ; 192: 146-153.
85. Stockmann-Juvala H. Naarala J. Loikkanen J. Vähäkangas K. Savolainen K.. Fumonisin B1-induced apoptosis in neuroblastoma, glioblastoma and hypothalamic cell lines. Toxicology 2006 ; 225: 234-241.
86. Bose R. Verheij M. Haimovitz-Friedman A. Scotto K. Fuks Z. Kolesnick R.. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995 ; 82: 405-414.
87. Wang H. Jones C. Ciacci-Zanella J. Holt T. Gilchrist DG. Dickman MB.. Fumonisins and Alternaria alternata lycopersici toxins: sphinganine analog mycotoxins induce apoptosis in monkey kidney cells. Proc Natl Acad Sci 1996 ; 93: 3461-3465.
88. Ciacci-Zanella JR. Merrill AH. Wang E. Jones C.. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells. Food Chem Toxicol 1998 ; 36: 791-804.
89. Ciacci-Zanella JR. Jones C.. Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation. Food Chem Toxicol 1999 ; 37: 703-712.
90. Jones C. Ciacci-Zanella JR. Zhang Y. Henderson G. Dickman M.. Analysis of fumonisin B1-induced apoptosis. Environ Health Perspect 2001 ; 109: 315-320.
91. Zhang Y. Jones C. Dickman MB.. Identification of differentially expressed genes following treatment of monkey kidney cells with the mycotoxin fumonisin B1. Food Chem Toxicol 2001 ; 39: 45-53.
92. Bhandari N. Sharma RP.. Fumonisin B1-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. Toxicology 2002 ; 172: 81-92.
93. Sharma N. Suzuki H. He Q. Sharma RP.. Tumor necrosis factor β-mediated activation of c-Jun NH2-terminal kinase as a mechanism for fumonisin B1 induced apoptosis in murine primary hepatocytes. J Biochem Mol Toxicol 2005 ; 19: 359-367.
94. Bhandari N. Sharma RP.. Modulation of selected cell signaling genes in mouse liver by fumonisin B1. Chem Biol Interact 2002 ; 139: 317-331.
95. Stockmann-Juvala H. Alenius H. Savolainen K.. Effects of fumonisin B1 on the expression of cytokines and chemokines in human dendritic cells. Food Chem Toxicol 2008 ; 46: 1444-1451.
96. Osuchowski MF. He Q. Sharma RP.. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood barrier. Food Chem Toxicol 2005 ; 43: 1389-1397.
97. Dugyala RR. Sharma RP. Tsunoda M. Riley RT.. Tumor necrosis factor-β as a contributor in fumonisin B1 toxicity. J Pharmacol Exp Ther 1998 ; 285: 317-324.
98. Liu B-H. Yu F-Y. Chan M-H. Yang Y-L.. The effects of mycotoxins, fumonisin B1 and aflatoxin B1, on primary swine alveolar macrophages. Toxicol Appl Pharmacol 2002 ; 180: 197-204.
99. Halloy DJ. Gustin PG. Bouchet S. Oswald IP.. Oral exposure to culture material extract containing fumonisins predisposes swine to the development of pneumonitis caused by Pasteurella multicoda. Toxicology 2005 ; 213: 34-44.
100. Taranu I. Marin DE. Bouchet S. Pascale F. Bailly J-D. Miller JD.. Mycotoxin fumonisin B1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs. Toxicol Sci 2005 ; 84: 301-307.